Toby et al., 2019 - Google Patents
A comprehensive pipeline for translational top-down proteomics from a single blood drawToby et al., 2019
View HTML- Document ID
- 18178666169791394015
- Author
- Toby T
- Fornelli L
- Srzentić K
- DeHart C
- Levitsky J
- Friedewald J
- Kelleher N
- Publication year
- Publication venue
- Nature protocols
External Links
Snippet
Top-down proteomics (TDP) by mass spectrometry (MS) is a technique by which intact proteins are analyzed. It has become increasingly popular in translational research because of the value of characterizing distinct proteoforms of intact proteins. Compared to bottom-up …
- 238000000575 proteomic 0 title abstract description 74
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
- G01N33/561—Immunoelectrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44743—Introducing samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8665—Signal analysis for calibrating the measuring apparatus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Toby et al. | A comprehensive pipeline for translational top-down proteomics from a single blood draw | |
Schubert et al. | Quantitative proteomics: challenges and opportunities in basic and applied research | |
Anjo et al. | SWATH‐MS as a tool for biomarker discovery: From basic research to clinical applications | |
Lyutvinskiy et al. | In silico instrumental response correction improves precision of label-free proteomics and accuracy of proteomics-based predictive models | |
Distler et al. | Label-free quantification in ion mobility–enhanced data-independent acquisition proteomics | |
Chambers et al. | Multiple Reaction Monitoring Enables Precise Quantification of 97 Proteins in Dried Blood Spots [S] | |
Rosenberger et al. | A repository of assays to quantify 10,000 human proteins by SWATH-MS | |
Everley et al. | Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research | |
Gillette et al. | Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry | |
Ronsein et al. | Deepening our understanding of HDL proteome | |
Nagaraj et al. | Detergent-based but gel-free method allows identification of several hundred membrane proteins in single LC-MS runs | |
Colantonio et al. | The clinical application of proteomics | |
Plebani | Proteomics: the next revolution in laboratory medicine? | |
Wessels et al. | LC‐MS/MS as an alternative for SDS‐PAGE in blue native analysis of protein complexes | |
Natsume et al. | BIA–MS–MS: biomolecular interaction analysis for functional proteomics | |
van Dongen et al. | LC–MS systems for quantitative bioanalysis | |
Cao et al. | Metabolomics‐proteomics profiles delineate metabolic changes in kidney fibrosis disease | |
Black et al. | Utilizing microchip capillary electrophoresis electrospray ionization for hydrogen exchange mass spectrometry | |
Kostas et al. | Simple and efficient microsolid-phase extraction tip-based sample preparation workflow to enable sensitive proteomic profiling of limited samples (200 to 10,000 cells) | |
Cho | Mass spectrometry-based proteomics in cancer research | |
Couchman et al. | LC-MS candidate reference methods for the harmonisation of parathyroid hormone (PTH) measurement: a review of recent developments and future considerations | |
Guo et al. | Technical advancement and practical considerations of LC-MS/MS-based methods for host cell protein identification and quantitation to support process development | |
Thomas et al. | Targeted proteomic assays for the verification of global proteomics insights | |
Roberts et al. | Top-down proteomics | |
Faca et al. | Innovative proteomic approaches for cancer biomarker discovery |